Authors: A. Fu
Affilation: NVIGEN, Inc., United States
Pages: 319 - 322
Keywords: nanoparticle drug delivery, theranostic reagents, nanoparticle-imaging-delivery, cancer nanotechnology
In this presentation, we will talk about a unique nanoparticle-imaging-delivery platform developed at NVIGEN, Inc. for enhanced cancer therapeutic applications. Our proprietary nanoparticle-imaging-delivery (NID™) technology is a hybrid platform comprised of an intrinsically signal-generating component (i.e. fluorescence and MRI) and a versatile conjugation component that can piggyback payloads for targeted drug delivery and simultaneous imaging. The controllable circulating half-life, the extremely enhanced permeability and retention effect, and the superior imaging and drug delivering properties of our nanoparticle formulation will be discussed.
Nanotech Conference Proceedings are now published in the TechConnect Briefs